Dendreon Corporation (NASDAQ:DNDN) will release the third quarter earnings for 2009 on Wednesday, November 11. The company will host a conference call at 4:30 pm ET that afternoon to discuss the financial results. Interested parties may hear the call by dialing 1.888.516.2435 or 1.719.457.2626 for international callers. A webcast of the presentation will also be available online at www.dendreon.com in the Investor Relations section for 30 days after the call. To hear a replay of the call, dial 1.888.203.1112 or 1.719.457.0820 for international callers. The conference ID number is 5275498. The replay will be accessible from 6:30 pm ET Wednesday, November 11 to 11:59 pm ET Friday, November 13.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter.
Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that improve cancer treatment options for patients. Dendreon’s most advanced product candidate is Provenge (sipuleucel-T), an active cellular immunotherapy that has completed two Phase III trials for the treatment of asymptomatic, metastatic, androgen-independent prostate cancer.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
